13 Cases Trimmed from Fresenius MDL Docket



DOCUMENTS
  • Order


BOSTON — The judge overseeing the federal MDL docket for claims relating to Fresenius’ GranuFlo and NaturaLyte dialysis products has dismissed 13 cases, ruling their claims are barred by the learned intermediary doctrine because their doctors were adequately warned that they could cause heart attacks.

In a Sept. 7 order, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts explained that physicians and facility staff at Fresenius dialysis units were provided memoranda that repeatedly cautioned of the risks of which plaintiffs complained.

GranuFlo and NaturaLyte, manufactured by Fresenius Medical Care North America Inc., are dry …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: Suboxone (Buprenorphine/Naloxone) Film Marketing, Sales Practices and Products Litigation - MDL No. 3092

December 18, 2023

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS